Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Melanoma leverages local cues to promote liver-specific metastasis

Using CRISPR–Cas9 screens, we found that cancer-cell-intrinsic loss of Pip4k2c conferred liver-metastatic organotropism in melanoma through hypersensitization to insulin-mediated PI3K–AKT signaling via co-optation of distinct hepatic metabolic cues. Additionally, we showed that combinatorial therapies that abolished physiological and drug-induced changes in glucose and insulin levels specifically reduced liver metastasis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Loss of Pip4k2c promotes liver-specific metastasis.

References

  1. Chaffer, C. L. & Weinberg, R. A. A perspective on cancer cell metastasis. Science 331, 1559–1564 (2011). This review article provides a comprehensive overview of tumor metastasis.

    Article  ADS  CAS  PubMed  Google Scholar 

  2. Tumeh, P. C. et al. Liver metastasis and treatment outcome with anti-PD-1 monoclonal antibody in patients with melanoma and NSCLC. Cancer Immunol. Res. 5, 417–424 (2017). This paper reports the effect of liver metastasis on the therapeutic response to anti-PD-1 therapy in patients with melanoma and non–small-cell lung cancer.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Bald, T. et al. Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 507, 109–113 (2014). This article presents the HCmel12 pre-clinical model and delineates the mechanism by which UVB-induced inflammation promotes metastasis.

    Article  ADS  CAS  PubMed  Google Scholar 

  4. US National Library of Medicine. Preventing high blood sugar in people being treated for metastatic breast cancer. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT05090358 (2023). This study assesses whether a ketogenic diet, low-carbohydrate diet or canagliflozin prevents high blood sugar, boosting cancer therapy in patients with metastatic PIK3CA-mutant breast cancer on alpelisib and fulvestrant.

  5. Hopkins, B. D. et al. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature 560, 499–503 (2018). This paper provides the first clues for enhancing the effectiveness of PI3K inhibitors by suppressing insulin feedback.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Rogava, M. et al. Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activation. Nature https://doi.org/10.1038/s43018-023-00704-x (2024).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Melanoma leverages local cues to promote liver-specific metastasis. Nat Cancer 5, 380–381 (2024). https://doi.org/10.1038/s43018-023-00705-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43018-023-00705-w

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer